Published July 2010 | Version v1
Journal article

DTPA: Bis benzimidazole as multi model imaging agent

  • 1. Institute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organisation, Delhi (India)

Description

Full text: The DTPA bis benzimidazole analogue has been tested for radiopharmaceutical efficacy. The radiolabelling was found more then 98% after 8 hrs and blood kinetics was fast. The compound was also tested for optical imaging agent. The Eu3+ ion has an absorption band in the visible spectrum (578-582 nm) whose wavelength is very sensitive to even small changes in the coordination environment. Although the intensity of this 7F0 → 5D0 transition is low, the bands are relatively narrow, which allows distinguishing different coordination states of the metal. For Eu3+ complexes which have two differently hydrated forms in aqueous solution, one observes two absorption bands belonging to the two species. High-resolution UV-visible spectra were recorded in aqueous solutions which show a temperature invariant absorption with two distinct, temperature-dependent absorption bands. The intensity ratio of these two bands changes with temperature: the band at shorter wavelengths is decreasing very slightly, while that at longer wavelengths is increasing with the temperature. The ratio of the integrals of the two bands is related to the equilibrium constant, and its temperature dependence yields the reaction enthalpy and entropy

Additional details

Publishing Information

Journal Title
Indian Journal of Nuclear Medicine
Journal Volume
25
Journal Issue
3
Journal Page Range
p. 85
CODEN
IJNMEK

Conference

Title
42. annual conference of the Society of Nuclear Medicine (India) on molecular imaging and targeted radionuclide therapy: predicting the future
Acronym
SNMICON-2010
Dates
11-14 Nov 2010
Place
Chandigarh (India)